Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Kobe2602
Cat. No.:
OB0225LY-0052
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR and LC-MS.
Size:
Product Overview
Description:
Kobe2602 is a small molecule inhibitor that targets specific biological pathways and has an important role in drug discovery and development.
Synonym:
454453-49-7; kobe-2602; 2-[2,6-Dinitro-4-(trifluoromethyl)phenyl]-N-(4-fluorophenyl)hydrazinecarbothioamide; 1-[2,6-Dinitro-4-(trifluoromethyl)anilino]-3-(4-fluorophenyl)thiourea; 3-{[2,6-Dinitro-4-(trifluoromethyl)phenyl]amino}-1-(4-fluorophenyl)thiourea; 2-(2,6-Dinitro-4-(trifluoromethyl)phenyl)-N-(4-fluorophenyl)hydrazinecarbothioamide; 2-(2,6-Dinitro-4-(trifluoromethyl)phenyl)-N-(4-fluorophenyl)hydrazine-1-carbothioamide; 2-[2,6-Dinitro-4-(trifluoromethyl)phenyl]-N-(4-fluorophenyl)-hydrazinecarbothioamide
CAS No.:
454453-49-7
Compound CID:
3827738
Formula:
C14H9F4N5O4S
Formula Weight:
419.31
Specification
Relative Density:
1.691 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Kobe2602 can be useful as Ras inhibitors in cancer and obesity research.
Library Information
Targets:
GTPase superfamily
Receptors:
Ras; Ras-Raf
Pathways:
GPCR/G protein; MAPK
Plate Number:
AOCL-1
Plate Location:
f4
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
50 mg/mL; 119.24 mM
